Pattern of care in adjuvant therapy for resected Stage I non-small cell lung cancer: real-world data from Japan-Reference-Cited by-同舟云学术

Pattern of care in adjuvant therapy for resected Stage I non-small cell lung cancer: real-world data from Japan

Published:2018-11-17 Issue:1 Volume:49 Page:63-68
ISSN:1465-3621
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Yoh Kiyotaka¹,Takamochi Kazuya²,Shukuya Takehito³,Hishida Tomoyuki⁴,Tsuboi Masahiro⁵,Sakurai Hiroyuki⁶,Goto Yasushi⁷,Yoshida Koichi⁸,Ohde Yasuhisa⁹,Okumura Sakae¹⁰,Ohashi Yasuo¹¹,Kunitoh Hideo¹²

Affiliation:

1. Department of Thoracic Oncology, National Cancer Center Hospital East

2. Department of General Thoracic Surgery, Juntendo University, Graduate School of Medicine

3. Department of Respiratory Medicine, Juntendo University, Graduate School of Medicine

4. Division of Thoracic Surgery, Department of Surgery, Keio University School of Medicine

5. Division of Thoracic Surgery & Oncology, National Cancer Center Hospital East

6. Division of Respiratory Surgery, Nihon University School of Medicine

7. Department of Thoracic Oncology, National Cancer Center Hospital

8. Department of Thoracic Surgery, Tokyo Medical University Hospital

9. Division of Thoracic Surgery, Shizuoka Cancer Center

10. Department of Thoracic Surgical Oncology, The Cancer Institute Hospital of JFCR

11. Integrated Science and Engineering for Sustainable Society, Chuo University

12. Department of Medical Oncology, Japanese Red Cross Medical Center, Japan

Funder

Taiho Pharmaceutical

Public Health Research

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/49/1/63/27565447/hyy165.pdf

Reference20 articles.

1. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours;Goldstraw;J Thorac Oncol,2007

2. Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade;Sawabata;J Thorac Oncol,2011

3. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group;Pignon;J Clin Oncol,2008

4. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung;Kato;N Engl J Med,2004

5. Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer;Hamada;J Clin Oncol,2005

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of epidermal growth factor receptor mutation on adjuvant chemotherapy with tegafur/uracil for patients with completely resected, non-lymph node metastatic non-small cell lung cancer (> 2 cm): a multicenter, retrospective, observational study as exploratory analysis of the CSPOR-LC03 study;Japanese Journal of Clinical Oncology;2024-09-11

2. Prognostic significance of ground-glass areas within tumours in non-small-cell lung cancer;European Journal of Cardio-Thoracic Surgery;2024-03-29

3. Adjuvant Osimertinib vs. Placebo in Completely Resected Stage IA2–IA3 EGFR-Mutated NSCLC: ADAURA2;Clinical Lung Cancer;2023-06

4. Adjuvant chemotherapy can benefit the survival of stage I lung adenocarcinoma patients with tumour spread through air spaces after resection: Propensity-score matched analysis;Frontiers in Oncology;2022-08-16

5. Efficacy of Adjuvant Chemotherapy With Tegafur-Uracil in Patients With Completely Resected, Node-Negative NSCLC—Real-World Data in the Era of Molecularly Targeted Agents and Immunotherapy;JTO Clinical and Research Reports;2022-05